Latest Features & Opinion
A hostile medical litigation climate is one of the major problems with the existing malpractice insurance system, driving significant losses of access to quality health care.
The main objection to nonreporting of negative results is that it contributes to a body of knowledge that is at best, incomplete, and at worst, wrong.
Latest in Autism Spectrum Disorder
All of the studies were small, including anywhere from 12 to 92 children, and they typically lasted less than 6 months.
Infants at risk for autism do better if therapists train parents to communicate more effectively.
The FDA has warned and/or taken action against a number of companies that have made improper claims about the intended use of their products to treat or cure autism.
Latest in Neuromuscular Disorders
Radicava is the first approved treatment for ALS in over 20 years.
Opicinumab may potentially enhance spontaneous remyelination after acute optic neuritis.
Emflaza is approved for the treatment of Duchenne muscular dystrophy regardless of genetic etiology.
Neurology Advisor Articles
- Serum Cytokine Levels May Correlate With Cognitive Dysfunction in Alzheimer's Disease
- Migraine-Associated Stroke Not Linked to Atherosclerosis
- Ptosis Repair Effective for Reducing Tension-Type Headache
- Intracranial Hemorrhage Associated with Arteriovenous Malformations Linked to Better Outcomes
- MRI-Guided Focused Ultrasound More Cost Effective Treatment for Essential Tremor
- In MS, Disease Duration, Lesion Load Predict Relapses and Disability Progression
- Stroke and Dementia Associated with Artificially-Sweetened Drinks?
- Case Report: DBS for the Treatment of Dystonia in Huntington's
- Treating Movement Disorders With Telemedicine: Getting Started
- Poor Quality of Sleep, Quality of Life in Patients With Lupus